06/24/2025
3:45 PM | BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:30 PM | FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:34 PM | Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:38 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:39 PM | FOUSE JACQUALYN A (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
3:22 PM | Madrigal Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/16/2025
5:23 PM | Madrigal Pharmaceuticals (Issuer)
Soergel David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
11:15 AM | JANUS HENDERSON GROUP PLC (Filed by)
Madrigal Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
05/01/2025
7:53 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2025
6:02 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2025
3:16 PM | Madrigal Pharmaceuticals (Filer)
| Form DEF 14A | |
Get the Latest News and Ratings for MDGL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
04/24/2025
4:03 PM | Madrigal Pharmaceuticals (Issuer)
Soergel David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
3:52 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2025
3:25 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
4:03 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2025
12:26 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144/A | |
03/12/2025
3:24 PM | FOUSE JACQUALYN A (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/12/2025
3:29 PM | FOUSE JACQUALYN A (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
3:32 PM | Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
3:11 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2025
7:05 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
4:43 PM | Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:47 PM | Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:40 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:00 PM | Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:50 PM | Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:31 PM | Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:31 PM | Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:07 PM | Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
8:24 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:27 PM | Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
3:59 PM | Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
3:31 PM | Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:36 PM | Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:51 PM | BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
3:54 PM | Daly James M (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2025
8:09 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2025
6:05 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
11:10 AM | JANUS HENDERSON GROUP PLC (Filed by)
Madrigal Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/27/2025
4:12 PM | Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
4:18 PM | Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
3..2..1.. AI 2.0 ignition (don’t sleep on this) (Ad) I just put together an urgent new presentation that you need to see right away.
In short: I believe we are mere days away from a critical announcement from a key tech leader…
One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.  Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
01/27/2025
4:07 PM | Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
4:03 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
5:00 PM | Madrigal Pharmaceuticals (Subject)
Sibold William John (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
5:00 PM | Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
5:00 PM | Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
5:00 PM | Madrigal Pharmaceuticals (Subject)
Taub Rebecca (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
6:05 PM | Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:08 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
6:10 PM | Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
4:30 PM | Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
4:30 PM | Madrigal Pharmaceuticals (Subject)
Taub Rebecca (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
4:30 PM | Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:50 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:46 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:16 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:10 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024
3:30 PM | Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
3:30 PM | Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
4:18 PM | Madrigal Pharmaceuticals (Subject)
PAULSON & CO. INC. (Filed by)
| Form SC 13G/A | |
11/14/2024
5:30 AM | Madrigal Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
11/08/2024
4:07 PM | Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
6:01 PM | Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:47 PM | Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:32 PM | Madrigal Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/31/2024
8:02 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
6:05 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
7:36 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
8:51 PM | Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
8:29 PM | Madrigal Pharmaceuticals (Subject)
Sibold William John (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
7:16 PM | Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
6:52 PM | Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2024
7:58 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
6:06 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
